Literature DB >> 1296815

Nucleotide sequence of the third cytokine LD78 gene and mapping of all three LD78 gene loci to human chromosome 17.

M Hirashima1, T Ono, M Nakao, H Nishi, A Kimura, H Nomiyama, F Hamada, M C Yoshida, K Shimada.   

Abstract

Cytokine LD78 is a member of a newly identified cytokine superfamily. We cloned the third human gene for the LD78, termed LD78 gamma and the sequence analysis showed that it is a 5'-truncated pseudogene. Exons 2 and 3 and the intron between them are highly homologous to those of the LD78 beta gene, hence, the gamma gene was probably derived from the beta gene. Southern blot analysis of human x mouse somatic hybrid cell DNAs and in situ hybridization experiments mapped all the three gene loci on human chromosome 17q21.1-q21.3. Analysis of DNAs from family members supports our previous finding that the beta and gamma genes on each of the paired chromosome 17 vary in copy number and that the LD78 alpha gene is presumably a single copy. In our analyses of cosmid clones, the LD78 beta gene and the second gene for AT744, which is also a member of the superfamily are closely linked in a head-to-head arrangement. The mechanism of generation of the three LD78 genes is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1296815     DOI: 10.3109/10425179209034019

Source DB:  PubMed          Journal:  DNA Seq        ISSN: 1026-7913


  9 in total

Review 1.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

Review 2.  Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.

Authors:  R Colobran; E Pedrosa; L Carretero-Iglesia; M Juan
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

3.  Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia.

Authors:  Toshiaki Nakajima; Hitoshi Ohtani; Taeko Naruse; Hiroki Shibata; Jun-Ich Mimaya; Hiroshi Terunuma; Akinori Kimura
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

4.  Characterization of cytokine LD78 gene promoters: positive and negative transcriptional factors bind to a negative regulatory element common to LD78, interleukin-3, and granulocyte-macrophage colony-stimulating factor gene promoters.

Authors:  H Nomiyama; K Hieshima; K Hirokawa; T Hattori; K Takatsuki; R Miura
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  MIP1 alpha nuclear protein (MNP), a novel transcription factor expressed in hematopoietic cells that is crucial for transcription of the human MIP-1 alpha gene.

Authors:  L M Ritter; M Bryans; O Abdo; V Sharma; N M Wilkie
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

6.  Genome diversification mechanism of rodent and Lagomorpha chemokine genes.

Authors:  Kanako Shibata; Hisayuki Nomiyama; Osamu Yoshie; Sumio Tanase
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

7.  Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population.

Authors:  M Paximadis; D B Schramm; G E Gray; G Sherman; A Coovadia; L Kuhn; C T Tiemessen
Journal:  Genes Immun       Date:  2012-11-15       Impact factor: 2.676

8.  Copy number variation of CCL3-like genes affects rate of progression to simian-AIDS in Rhesus Macaques (Macaca mulatta).

Authors:  Jeremiah D Degenhardt; Paola de Candia; Adrien Chabot; Stuart Schwartz; Les Henderson; Binhua Ling; Meredith Hunter; Zhaoshi Jiang; Robert E Palermo; Michael Katze; Evan E Eichler; Mario Ventura; Jeffrey Rogers; Preston Marx; Yoav Gilad; Carlos D Bustamante
Journal:  PLoS Genet       Date:  2009-01-23       Impact factor: 5.917

9.  Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.

Authors:  J Southgate; J Proffitt; P Roberts; B Smith; P Selby
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.